来自专业的译者、企业、网页和免费的翻译库。
bivirkningene i studie d2302 (transforms), en 1-årig studie med 849 pasienter behandlet med fingolimod og interferon beta-1a som sammenligningspreparat, var generelt de samme som for placebokontrollerte studier, tatt i betraktning forskjellene i studienes varighet.
the adverse reactions in study d2302 (transforms), a 1-year study in 849 patients treated with fingolimod which used interferon beta-1a as comparator, were generally similar to placebo-controlled studies, taking into account the differences in study duration.